Why the study?
Does diabetes mellitus and its preadmission treatment impact one-year mortality in patients with acute STEMI treated with primary PCI?
Does diabetes mellitus and its preadmission treatment impact one-year mortality in patients with acute STEMI treated with primary PCI?
This study aims to evaluate the impact of diabetes and its preadmission treatment on one-year mortality in STEMI patients undergoing primary PCI.
No takes yet. Share an insight, caveat, or question.
Diabetes and preadmission treatment may affect one-year mortality after primary PCI in STEMI; this cohort analysis leaves open causal inference and practice change.
René J. van der Schaaf (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: